AB4AD (Antibodies for Alzheimer's Disease) is not active.
Cryptocurrency List
#7224 AB4AD (Antibodies for Alzheimer's Disease)
Current trading data unavailable
$ 7.9 ths.
Maximum supply: 1 000 000 tokens.
FDV / market cap: 0.18×.
A value below 1 can reflect different timestamps or methods in the underlying data.
Saved supply is used; its verification date is unknown.
Calculated using the last available price; quote freshness is unconfirmed.
Price: low and high
How the range is calculated
24h uses saved quotes from the last 24 hours. The 30-day and one-year views use daily lows and highs for UTC calendar days, including today. Gaps are not filled; prices may have differed between samples. The dot marks the current price, not a buy signal.
All time uses CoinGecko’s USD ATL and ATH. Other currencies use the current exchange rate; these are not historical records in the selected currency.
Exchanges where AB4AD is traded
No dataCalculator AB4AD
1 AB4AD = 0.0079 USD
What is AB4AD (Antibodies for Alzheimer's Disease)?
Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).
Official websites and links for AB4AD (Antibodies for Alzheimer's Disease)
There are currently about 3 official links to AB4AD (Antibodies for Alzheimer's Disease) websites and social media:
- Website - molecule.xyz/ipts/ab4ad
- Twitter - twitter.com/AB4AD_
- Facebook - facebook.com